Nonsteroide antiinflammatoriske farmaka og forebyggelse af kolorektalcancer og andre former for cancer.
Sørensen, Henrik Toft; Nørgård, Bente; Friis, Søren; Laurberg, Søren; Olsen, Jørgen H; Kronberg, Ole.
; 165(12): 1260-1, 2003 Mar 17.
Artigo em Dinamarquês | MEDLINE | ID: mdl-12701310
Aspirin for the Prevention of Cancer Incidence and Mortality: Systematic Evidence Reviews for the U.S. Preventive Services Task Force.
Long-term use of low-dose aspirin for cancer prevention: A 10-year population cohort study in Hong Kong.
The practical use of acetylsalicylic acid in the era of the ASPRE trial. Update and literature review.
Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials.
Non-steroidal anti-inflammatory drugs and cancer risk in women: results from the Women's Health Initiative.
Low-Dose Aspirin or Nonsteroidal Anti-inflammatory Drug Use and Colorectal Cancer Risk: A Population-Based, Case-Control Study.
Aspirin and colorectal cancer: back to the future.
Safety and efficacy of aspirin for primary prevention of cancer: a meta-analysis of randomized controlled trials.
Jury still out on low-dose aspirin and cancer.
Blood levels of long-chain polyunsaturated fatty acids, aspirin, and the risk of colorectal cancer.